Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viking Thera (NQ: VKTX )

56.52 -4.73 (-7.72%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,322,220
Open 61.87
Bid (Size) 56.71 (1)
Ask (Size) 57.00 (1)
Prev. Close 61.25
Today's Range 56.40 - 62.79
52wk Range 8.280 - 99.41
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Better Weight Loss Drug Stock: Viking Therapeutics vs. Zealand Pharma
Both companies have a clear path to competing successfully in the market. 
Via The Motley Fool

Performance

YTD
+209.19%
+209.19%
1 Month
+2.17%
+2.17%
3 Month
-28.98%
-28.98%
6 Month
+137.28%
+137.28%
1 Year
+289.79%
+289.79%

More News

Read More
3 Overlooked Stocks Poised for a Breakout Very Soon
Via InvestorPlace
Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why.
Via The Motley Fool
Topics Economy
Exposures Interest Rates
The Bull Case for Viking Therapeutics Just Got Even Stronger. Here's Why You Should Buy It.
Via The Motley Fool
Viking Therapeutics's Options: A Look at What the Big Money is Thinking
Via Benzinga
Attention, Growth Investors: This Biotech Stock Is Crushing Nvidia.
Via The Motley Fool
ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
Via Benzinga
Is Viking Therapeutics a Millionaire-Maker Stock?
Via The Motley Fool
Stock Market Diverges, With Tesla, Google, ServiceNow, GE In Focus: Weekly Review
Via Investor's Business Daily
Why Weight Loss Drug Developer Stocks Tumbled on Thursday
Via The Motley Fool
Novo Nordisk Shares Decline Amid Competitive Pressure
Via Benzinga
Gold Down 2.5%; Northrop Grumman Posts Upbeat Earnings
Via Benzinga
Viking Therapeutics Stock Surges As Company Advances Weight Loss Drug To Late-Stage Trial: What Investors Need To Know
Via Benzinga
Nasdaq Gains 1%; American Airlines Cuts Earnings Forecast
Via Benzinga
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
IBM Posts Upbeat Earnings, Joins ServiceNow, Helmerich & Payne, RTX, Nasdaq And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Why Eli Lilly and Company Shares Are Moving Lower On Thursday
Via Benzinga
Viking Therapeutics: Pharma Stock Soars on Positive Earnings
Via MarketBeat
Topics Earnings
Exposures Financial
Why Viking Therapeutics Stock Is Skyrocketing Today
Via The Motley Fool
CON Stock: 7 Things to Know as Concentra Group Starts Trading Today
Via InvestorPlace
Topics Initial Public Offering
Exposures Securities Market
Viking Therapeutics Unveils Monthly Weight-Loss Shot, And Rocks Eli Lilly, Novo Nordisk
Via Investor's Business Daily
Goodbye Open Seating! Southwest Airlines Announces Major Policy Shift.
Via InvestorPlace
Viking Therapeutics (VKTX) Stock Pops on Plans to Start Late-Stage Weight Loss Drug Trials
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.